Management of psoriasis-like rash associated with idelalisib monotherapy in a patient with refractory follicular lymphoma: a case report
Abstract Background Follicular lymphoma is an indolent non-Hodgkin lymphoma that is most commonly diagnosed in elderly individuals. The majority of patients with follicular lymphoma present with advanced disease. Despite the recent advances in treatment, there remains a substantial unmet need for ef...
Main Authors: | Salma Machan, Carlos Plaza, Yosmar Pérez-González, Maria Rodriguez-Pinilla, Luis Requena, Raul Cordoba |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13256-020-2344-9 |
Similar Items
-
Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas
by: Madanat YF, et al.
Published: (2016-03-01) -
Idelalisib in a patient with refractory Waldenström’s macroglobulinemia complicated by anuric renal failure: a case report
by: M. D’Aveni-Piney, et al.
Published: (2018-06-01) -
Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential
by: Barrientos JC
Published: (2016-05-01) -
Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia
by: Sara E. F. Kost, et al.
Published: (2019-10-01) -
Idelalisib may have the potential to increase radiotherapy side effects
by: Thomas Gryc, et al.
Published: (2017-06-01)